Heart-brain co-ageing: coupled but non-synchronous ageing of heart, vessels and brain
This review proposes heart-brain co-ageing as a testable framework: heart, vessels and brain age along partly coupled but non-synchronous trajectories, with distinct clinical phenotypes and candidate shared mechanisms. Evidence comes from a literature search with narrative synthesis, not new data. [1]
Automatic summary · not editorially reviewed
The key findings
The authors propose heart-brain co-ageing as a testable conceptual framework with explicit operational criteria distinguishing coupled from parallel organ ageing. [1]
The review used a hybrid design combining a systematic literature search with narrative synthesis. [1]
Candidate shared mechanisms include cellular senescence, chronic low-grade inflammation and mitochondrial dysfunction, among others. [1]
The source at a glance
- Study type / format
- Review using a hybrid design: systematic literature search with narrative synthesis (abstract only).
- Population / context
- Older adults, as discussed in the reviewed literature; no participants were studied in this review.
- Summary based on
- Study abstract
- Original publication
- October 14, 2026
Review asks how heart, vessels and brain age together
Population ageing has raised the burden of cardiovascular disease, cognitive decline and frailty in older adults. These conditions are often studied separately, yet growing evidence suggests the ageing heart, vasculature and brain are biologically interconnected. The authors argue heart-brain co-ageing is not simply cardiovascular and neurological disease existing side by side, but a dynamic multi-organ ageing process. They propose it as a testable conceptual framework with explicit operational criteria separating coupled from parallel organ ageing.
Supporting source [1]
Literature search plus narrative synthesis, no new participants
The authors used a hybrid design combining a systematic literature search with narrative synthesis. The review summarizes current knowledge on heart-brain co-ageing, focusing on phenotypic heterogeneity, molecular mechanisms and translational interventions. No new participants were studied and no new measurements were collected; the work draws together existing published evidence rather than testing the framework directly.
Supporting source [1]
Five phenotypes and candidate shared mechanisms, standardization limited
The review describes five major clinical phenotypes: vascular-dominant ageing, cardiac-output-related brain vulnerability, arrhythmia-associated thromboinflammatory injury, frailty-cognitive decline and metabolic-inflammatory co-ageing. These differ in risk profiles, dominant mechanisms and potential biomarkers. Candidate shared mechanisms include cellular senescence, chronic low-grade inflammation, mitochondrial dysfunction, oxidative stress, endothelial impairment, blood-brain barrier disruption, epigenetic remodelling, telomere attrition, non-coding RNA regulation, Klotho signalling, nicotinamide adenine dinucleotide metabolism and microbiome-derived metabolic signalling. Multimodal imaging, circulating biomarkers, biological ageing clocks and multi-omics profiling may aid risk stratification, but clinical standardization remains limited. These are proposed mechanisms and opportunities, not demonstrated causes or proven interventions.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. This is a review using a literature search and narrative synthesis, not new data. Proposed phenotypes, mechanisms and interventions are a conceptual framework, not demonstrated causes or proven treatments.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Huang H, Zhang W, Hou C, Lu X, Ruan H, Liu J, Lei T, Chen S, Chen M, Liu Y. · europepmc.org · October 14, 2026